NOT KNOWN DETAILS ABOUT BRD4 INHIBITION BY ABBV-744 IN CANCER RESEARCH STUDIES

These side effects have been notably milder when compared with an inhibitor of each bromodomains. A detailed molecular Investigation also exposed that ABBV-744 preferentially inhibits the expression of Androgen Receptor (AR)-dependent genes.  ― Stephen Taylor88 These preclinical studies supply paradigms for long run clinical trials in AML, and u